1. Home
  2. HCM vs ATKR Comparison

HCM vs ATKR Comparison

Compare HCM & ATKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • ATKR
  • Stock Information
  • Founded
  • HCM 2000
  • ATKR 1959
  • Country
  • HCM Hong Kong
  • ATKR United States
  • Employees
  • HCM N/A
  • ATKR N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • ATKR Industrial Machinery/Components
  • Sector
  • HCM Health Care
  • ATKR Miscellaneous
  • Exchange
  • HCM Nasdaq
  • ATKR Nasdaq
  • Market Cap
  • HCM 2.5B
  • ATKR 2.2B
  • IPO Year
  • HCM N/A
  • ATKR 2016
  • Fundamental
  • Price
  • HCM $13.89
  • ATKR $65.09
  • Analyst Decision
  • HCM Hold
  • ATKR Buy
  • Analyst Count
  • HCM 1
  • ATKR 6
  • Target Price
  • HCM $19.00
  • ATKR $77.50
  • AVG Volume (30 Days)
  • HCM 62.8K
  • ATKR 408.6K
  • Earning Date
  • HCM 03-19-2025
  • ATKR 05-06-2025
  • Dividend Yield
  • HCM N/A
  • ATKR 2.03%
  • EPS Growth
  • HCM N/A
  • ATKR N/A
  • EPS
  • HCM 0.04
  • ATKR 5.38
  • Revenue
  • HCM $630,201,000.00
  • ATKR $2,973,983,000.00
  • Revenue This Year
  • HCM $14.86
  • ATKR N/A
  • Revenue Next Year
  • HCM $19.54
  • ATKR $2.33
  • P/E Ratio
  • HCM $63.20
  • ATKR $12.10
  • Revenue Growth
  • HCM N/A
  • ATKR N/A
  • 52 Week Low
  • HCM $11.51
  • ATKR $49.92
  • 52 Week High
  • HCM $21.50
  • ATKR $153.32
  • Technical
  • Relative Strength Index (RSI)
  • HCM 50.07
  • ATKR 47.15
  • Support Level
  • HCM $13.13
  • ATKR $63.94
  • Resistance Level
  • HCM $13.66
  • ATKR $68.62
  • Average True Range (ATR)
  • HCM 0.36
  • ATKR 1.81
  • MACD
  • HCM 0.05
  • ATKR -0.54
  • Stochastic Oscillator
  • HCM 81.25
  • ATKR 13.23

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: